Literature DB >> 16537370

Inhibitor-binding mode of homobelactosin C to proteasomes: new insights into class I MHC ligand generation.

Michael Groll1, Oleg V Larionov, Robert Huber, Armin de Meijere.   

Abstract

Most class I MHC ligands are generated from the vast majority of cellular proteins by proteolysis within the ubiquitin-proteasome pathway and are presented on the cell surface by MHC class I molecules. Here, we present the crystallographic analysis of yeast 20S proteasome in complex with the inhibitor homobelactosin C. The structure reveals a unique inhibitor-binding mode and provides information about the composition of proteasomal primed substrate-binding sites. IFN-gamma inducible substitution of proteasomal constitutive subunits by immunosubunits modulates characteristics of generated peptides, thus producing fragments with higher preference for binding to MHC class I molecules. The structural data for the proteasome:homobelactosin C complex provide an explanation for involvement of immunosubunits in antigen generation and open perspectives for rational design of ligands, inhibiting exclusively constitutive proteasomes or immunoproteasomes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537370      PMCID: PMC1450213          DOI: 10.1073/pnas.0600647103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

2.  Conformational constraints for protein self-cleavage in the proteasome.

Authors:  L Ditzel; R Huber; K Mann; W Heinemeyer; D H Wolf; M Groll
Journal:  J Mol Biol       Date:  1998-06-26       Impact factor: 5.469

3.  The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing.

Authors:  W Heinemeyer; M Fischer; T Krimmer; U Stachon; D H Wolf
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

4.  The catalytic sites of 20S proteasomes and their role in subunit maturation: a mutational and crystallographic study.

Authors:  M Groll; W Heinemeyer; S Jäger; T Ullrich; M Bochtler; D H Wolf; R Huber
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes.

Authors:  M Gaczynska; K L Rock; A L Goldberg
Journal:  Nature       Date:  1993-09-16       Impact factor: 49.962

6.  Structure of 20S proteasome from yeast at 2.4 A resolution.

Authors:  M Groll; L Ditzel; J Löwe; D Stock; M Bochtler; H D Bartunik; R Huber
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

7.  A protein catalytic framework with an N-terminal nucleophile is capable of self-activation.

Authors:  J A Brannigan; G Dodson; H J Duggleby; P C Moody; J L Smith; D R Tomchick; A G Murzin
Journal:  Nature       Date:  1995-11-23       Impact factor: 49.962

8.  LMP2+ proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes.

Authors:  C Sibille; K G Gould; K Willard-Gallo; S Thomson; A J Rivett; S Powis; G W Butcher; P De Baetselier
Journal:  Curr Biol       Date:  1995-08-01       Impact factor: 10.834

9.  MHC class I expression in mice lacking the proteasome subunit LMP-7.

Authors:  H J Fehling; W Swat; C Laplace; R Kühn; K Rajewsky; U Müller; H von Boehmer
Journal:  Science       Date:  1994-08-26       Impact factor: 47.728

10.  Interferon-gamma can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase.

Authors:  J Beninga; K L Rock; A L Goldberg
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

View more
  16 in total

Review 1.  Proteasome inhibitors: an expanding army attacking a unique target.

Authors:  Alexei F Kisselev; Wouter A van der Linden; Herman S Overkleeft
Journal:  Chem Biol       Date:  2012-01-27

2.  α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells.

Authors:  Martina Bazzaro; Ravi K Anchoori; Mohana Krishna R Mudiam; Olga Issaenko; Srinivas Kumar; Balasubramanyam Karanam; Zhenhua Lin; Rachel Isaksson Vogel; Riccardo Gavioli; Federica Destro; Valeria Ferretti; Richard B S Roden; Saeed R Khan
Journal:  J Med Chem       Date:  2010-12-27       Impact factor: 7.446

3.  A strategy for dual inhibition of the proteasome and fatty acid synthase with belactosin C-orlistat hybrids.

Authors:  Mingzhao Zhu; Wayne D Harshbarger; Omar Robles; Joanna Krysiak; Kenneth G Hull; Sung Wook Cho; Robyn D Richardson; Yanyan Yang; Andres Garcia; Lindsey Spiegelman; Bianca Ramirez; Christopher T Wilson; Ju Anne Yau; James T Moore; Caitlen B Walker; James C Sacchettini; Wenshe R Liu; Stephan A Sieber; Jeffrey W Smith; Daniel Romo
Journal:  Bioorg Med Chem       Date:  2017-01-19       Impact factor: 3.641

4.  Proteasomal cleavage site prediction of protein antigen using BP neural network based on a new set of amino acid descriptor.

Authors:  Yuanqiang Wang; Yong Lin; Mao Shu; Rui Wang; Yong Hu; Zhihua Lin
Journal:  J Mol Model       Date:  2013-04-13       Impact factor: 1.810

Review 5.  Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents.

Authors:  A M Mfuh; O V Larionov
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

6.  Structural analysis of spiro beta-lactone proteasome inhibitors.

Authors:  Michael Groll; Emily P Balskus; Eric N Jacobsen
Journal:  J Am Chem Soc       Date:  2008-10-17       Impact factor: 15.419

Review 7.  Advances in and applications of proteasome inhibitors.

Authors:  Bradley S Moore; Alessandra S Eustáquio; Ryan P McGlinchey
Journal:  Curr Opin Chem Biol       Date:  2008-07-24       Impact factor: 8.822

8.  Design, synthesis, and evaluation of cystargolide-based β-lactones as potent proteasome inhibitors.

Authors:  Doleshwar Niroula; Liam P Hallada; Camille Le Chapelain; Susantha K Ganegamage; Devon Dotson; Snezna Rogelj; Michael Groll; Rodolfo Tello-Aburto
Journal:  Eur J Med Chem       Date:  2018-08-20       Impact factor: 6.514

9.  Global analysis of biosynthetic gene clusters reveals conserved and unique natural products in entomopathogenic nematode-symbiotic bacteria.

Authors:  Yi-Ming Shi; Merle Hirschmann; Yan-Ni Shi; Shabbir Ahmed; Desalegne Abebew; Nicholas J Tobias; Peter Grün; Jan J Crames; Laura Pöschel; Wolfgang Kuttenlochner; Christian Richter; Jennifer Herrmann; Rolf Müller; Aunchalee Thanwisai; Sacha J Pidot; Timothy P Stinear; Michael Groll; Yonggyun Kim; Helge B Bode
Journal:  Nat Chem       Date:  2022-04-25       Impact factor: 24.274

10.  Ubiquitin-independent proteosomal degradation of myelin basic protein contributes to development of neurodegenerative autoimmunity.

Authors:  Alexey Belogurov; Ekaterina Kuzina; Anna Kudriaeva; Alexey Kononikhin; Sergey Kovalchuk; Yelena Surina; Ivan Smirnov; Yakov Lomakin; Anna Bacheva; Alexey Stepanov; Yaroslava Karpova; Yulia Lyupina; Oleg Kharybin; Dobroslav Melamed; Natalia Ponomarenko; Natalia Sharova; Eugene Nikolaev; Alexander Gabibov
Journal:  FASEB J       Date:  2015-01-29       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.